ENTRIES TAGGED "genetics"
"Like a spaceship that was parked in our back yard"
Michael Italia on making use of data collected in health care settings.
Michael Italia from Children's Hospital of Philadelphia discusses the tools and methods his team uses to manage health care data.
Can open data dominate biological science as open source has in software?
To move from a hothouse environment of experimentation to the mainstream of one of the world's most lucrative and tradition-bound industries, Sage Bionetworks must aim for its nucleus: rewards and incentives. Comparisons to open source software and a summary of tasks for Sage Congress.
The Vioxx problem is just one instance of the wider malaise afflicting the drug industry. Managers from major pharma companies expressed confidence that they could expand public or "pre-competitive" research in the direction Sage Congress proposed. The sector left to engage is the one that's central to all this work–the public.
Report from a movement that believes in open source and open data in science
Through two days of demos, keynotes, panels, and breakout sessions, Sage Congress brought its vision to a high-level cohort of 230 attendees from universities, pharmaceutical companies, government health agencies, and others who can make change in the field.
Complex health problems are too big for a single team.
A conversation with Sage Bionetworks founder Stephen Friend about how open source can support a business model in drug development, the progress of current data sharing projects, and more.
The final installment of this series, about a Sage Commons Congress on
the open-source sharing of genetic research, looks at what Sage
Bionetworks and its friends need to do.
The fourth installment of this series, about a Sage Commons Congress on
the open-source sharing of genetic research, focuses in on the rights
of patients and how they want researchers to treat their data.
The third installment of this series, about a Sage Commons Congress on
the open-source sharing of genetic research, explores the barriers
that keep private companies and researchers from sharing their work.